SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-24-000002
Filing Date
2024-01-04
Accepted
2024-01-04 13:01:14
Documents
2
Period of Report
2024-01-04

Document Format Files

Seq Description Document Type Size
1 6-K form6kupdateletter.htm 6-K 18203
2 EX-99.1 oncyupdateletter.htm EX-99.1 32840
  Complete submission text file 0001129928-24-000002.txt   52038
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 24510909
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)